Simple biological age score linked to cognitive decline risk in older adults

Your doctor knows your age. But your body might be aging faster—or slower—than the calendar suggests. A new study of nearly 5,000 middle-aged and older Chinese adults found that a simple biological age score, calculated from four routine blood measurements, could flag who is at risk for cognitive decline better than chronological age alone.

The score, called light BioAge, uses only four numbers: your actual age, plus levels of creatinine, glucose, and C-reactive protein—all things a standard blood test already measures. Researchers from the China Health and Retirement Longitudinal Study tracked participants from 2011 to 2020, watching who developed memory problems, mental fog, or cognitive impairment as they aged. The finding was striking: people whose light BioAge score was 56.82 years or higher faced substantially higher risks of cognitive problems than those scoring below 42.45 years, even after accounting for their actual chronological age.

Cognitive impairment—a decline in memory, reasoning, attention, or language that goes beyond normal aging—affects roughly one in six adults over 50 worldwide, and nearly one in five in China. It ranges from mild forgetfulness to severe dementia. The condition ripples outward: it damages psychological well-being, isolates people from social life, weakens physical function, and strains healthcare systems. We know age itself is the biggest risk factor, but so are heart disease, high blood pressure, obesity, diabetes, smoking, depression, and lack of exercise. What happens inside the aging brain is equally complex—the hippocampus shrinks, inflammation rises, amyloid proteins accumulate, and neurons become fragile.

The problem is that chronological age tells an incomplete story. Two 70-year-olds can be biologically very different. Researchers have developed elaborate biological aging clocks—some based on DNA methylation patterns—but these require expensive tests and complex calculations, making them impractical for everyday medicine. Light BioAge was designed to be simple. It asks: what if you could use four routine measurements to capture how fast someone's body is actually aging?

In this study, researchers followed 4,818 participants who had no cognitive impairment at the start. Over the follow-up period, nearly a quarter developed cognitive impairment, 40.7% showed decline in mental sharpness, and 35.1% experienced memory decline. When researchers analyzed the data, controlling for actual age and other health factors, higher light BioAge scores remained linked to all three types of cognitive decline. The effect was modest but consistent: adding light BioAge to standard age-based predictions improved the model's accuracy across all cognitive outcomes.

But the researchers were careful about what they claimed. Light BioAge is not yet ready for the clinic. The study was conducted in China, and findings need validation in other populations. The cognitive impairment was identified through survey-based testing, not clinical diagnosis. The study cannot prove that biological aging causes cognitive decline—only that the two are associated. And the added predictive power, while real, was small. Light BioAge might work as an epidemiological tool for identifying high-risk groups, but its ability to predict individual risk remains limited.

What the study does suggest is that the body's aging rate—captured in four simple numbers—carries information about the brain's future that age alone does not. Before light BioAge becomes a routine screening tool, it will need to be tested in diverse populations, validated against clinical diagnoses, and shown to help doctors make better decisions about who needs early intervention. For now, it remains a promising marker, a reminder that how we age biologically matters as much as how many years we have lived.